Drug treatment of haematemesis and melaena.
Despite generally held beliefs to the contrary, worthwhile improvements in outcome in patients with haematemesis and melaena may be achievable with H2 antagonist or antifibrinolytic treatment.
D006396:Hematemesis / Q000188:drug therapy*; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D008551:Melena / Q000188:drug therapy*; D013004:Somatostatin / Q000627:therapeutic use; D014148:Tranexamic Acid / Q000627:therapeutic use
D006635:Histamine H2 Antagonists; D013004:Somatostatin; D014148:Tranexamic Acid